Fundraising FoxJuventas Therapeutics
Cleveland, US · Founded 2007 · Delaware corporation · 6 known investors
Find your way into Juventas Therapeutics
Sign up to see every warm intro you have to Juventas Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Juventas Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Juventas Therapeutics was founded in 2007 by Marc Penn.
MP
Marc PennFounder
TI
RA
Rahul ArasNamed on SEC filing
Board
Investors · 6
Panacea Venturelisted by Panacea VentureSingapore
How we know: Panacea Venture's portfolio page · Not right? Tell us
Clarevia VenturesreportedMadison · $250K – $2.5M
How we know: funding news · Not right? Tell us
Early Stage Partners, LPreportedCleveland
How we know: funding news · Not right? Tell us
New Science VenturesreportedGreenwich · $2M – $8M
How we know: funding news · Not right? Tell us
Takeda VenturesreportedCambridge · $1M – $5M
How we know: funding news · Not right? Tell us
Triathlon Medical Venture Partnersreported
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$20.7M disclosed across 3 rounds · 2008–2017
▶$1.3MraisedOct 2017 · 46 investors · BiotechnologyRule 506(b)
▶$1.3MraisedOct 2017 · 46 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew PollmanExecutive Officer, Director
- Linda TuftsDirector
- George AridaDirector
- James BolandDirector
- Suzette DutchDirector
- Rahul ArasExecutive Officer, Director
- Roger NewtonDirector
- Jack MinerDirector
- Offering amount
- $6M
- Amount sold
- $1.3M
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.4MraisedMay 2015 · 37 investors · BiotechnologyRule 506(b)
▶$7.4MraisedMay 2015 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Suzette DutchDirector
- Marc PennExecutive Officer, Director
- Roger NewtonDirector
- George AridaDirector
- Linda TuftsDirector
- Matthew PollmanDirector
- Troy IgnelziExecutive Officer
- Rahul ArasExecutive Officer, Director
- James BolandDirector
- Somu SubramaniamDirector
- Offering amount
- $7.4M
- Amount sold
- $7.4M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$12MraisedFeb 2012 · 34 investors · BiotechnologyRule 506(b)
▶$12MraisedFeb 2012 · 34 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Somu SubramaniamDirector
- Matt PollmanDirector
- Rahul ArasExecutive Officer, Director
- Roger NewtonDirector
- Linda TuftsDirector
- Marc PennDirector
- George EmontDirector
- Offering amount
- $20M
- Amount sold
- $12M
- First sale
- Sep 2008
- Incorporated
- Corporation, Delaware, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Juventas Therapeutics?
- Juventas Therapeutics was founded by Marc Penn in 2007.
- Who are Juventas Therapeutics's investors?
- Juventas Therapeutics's investors include Panacea Venture, Clarevia Ventures, Early Stage Partners, LP, New Science Ventures, Takeda Ventures, Triathlon Medical Venture Partners.
- How much funding has Juventas Therapeutics raised?
- Juventas Therapeutics has disclosed $20.7M raised across 3 rounds.
- Where is Juventas Therapeutics headquartered?
- Juventas Therapeutics is headquartered in Cleveland, US.